CanSino Biologics Inc. (HKG: 6185)
Hong Kong
· Delayed Price · Currency is HKD
29.95
-0.10 (-0.33%)
Nov 15, 2024, 10:48 AM HKT
CanSino Biologics Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2016 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2016 |
Cash & Equivalents | 1,364 | 2,822 | 3,465 | 5,645 | 4,447 | 643.27 | Upgrade
|
Short-Term Investments | - | - | - | 275.2 | - | - | Upgrade
|
Trading Asset Securities | 1,919 | 1,308 | 2,482 | 1,862 | 666.64 | 111.53 | Upgrade
|
Cash & Short-Term Investments | 3,283 | 4,130 | 5,947 | 7,783 | 5,114 | 754.79 | Upgrade
|
Cash Growth | -24.39% | -30.55% | -23.59% | 52.19% | 577.49% | 282.40% | Upgrade
|
Accounts Receivable | 678.06 | 636.88 | 855.49 | 157.93 | 22.14 | - | Upgrade
|
Other Receivables | 9.27 | 3.98 | 0.54 | 19.15 | 0.25 | 0.02 | Upgrade
|
Receivables | 687.32 | 640.87 | 856.03 | 177.08 | 22.4 | 0.02 | Upgrade
|
Inventory | 345.07 | 352.85 | 677.78 | 875.62 | 170.51 | 16.34 | Upgrade
|
Prepaid Expenses | - | 0.25 | - | - | - | - | Upgrade
|
Other Current Assets | 53.71 | 57 | 249.59 | 454.49 | 114.07 | 23.1 | Upgrade
|
Total Current Assets | 4,369 | 5,181 | 7,730 | 9,290 | 5,421 | 794.25 | Upgrade
|
Property, Plant & Equipment | 2,491 | 3,013 | 3,069 | 2,218 | 873.95 | 574.89 | Upgrade
|
Long-Term Investments | 165.97 | 446.56 | 50.12 | 45.31 | 265.44 | 306.87 | Upgrade
|
Other Intangible Assets | 119.16 | 144.15 | 220.92 | 172.12 | 36.9 | 19.81 | Upgrade
|
Long-Term Deferred Tax Assets | 206.38 | 207.86 | 196.41 | - | - | - | Upgrade
|
Long-Term Deferred Charges | 168.24 | 88.4 | 51.95 | 26.19 | 43.37 | 52.22 | Upgrade
|
Other Long-Term Assets | 469.77 | 237.53 | 150.37 | 122.42 | 107.78 | 36.47 | Upgrade
|
Total Assets | 7,990 | 9,319 | 11,469 | 11,874 | 6,748 | 1,784 | Upgrade
|
Accounts Payable | 72.54 | 103.97 | 253.12 | 842.57 | 60.57 | 6.17 | Upgrade
|
Accrued Expenses | 41.94 | 453.14 | 407.25 | 362.44 | 157.82 | 23.48 | Upgrade
|
Short-Term Debt | 596.88 | 883.97 | 1,530 | 990.68 | - | - | Upgrade
|
Current Portion of Long-Term Debt | 531.95 | 510.59 | 45.77 | 90.11 | 40.16 | 20.24 | Upgrade
|
Current Portion of Leases | - | 64.63 | 48.76 | 31.18 | 8.59 | 8.8 | Upgrade
|
Current Income Taxes Payable | 23.9 | 0.54 | 3 | 29.14 | - | 0.01 | Upgrade
|
Current Unearned Revenue | 10.99 | 3.57 | 1.48 | 193.22 | 0.42 | 0.58 | Upgrade
|
Other Current Liabilities | 493.4 | 544.9 | 635.52 | 322.08 | 141.91 | 57.14 | Upgrade
|
Total Current Liabilities | 1,772 | 2,565 | 2,925 | 2,861 | 409.47 | 116.43 | Upgrade
|
Long-Term Debt | 962.12 | 1,066 | 878.01 | 40 | 90 | 130 | Upgrade
|
Long-Term Leases | 11.35 | 175.18 | 198.29 | 222.85 | 3.79 | 7.76 | Upgrade
|
Long-Term Unearned Revenue | 181.08 | 216.72 | 222.35 | 201.48 | 173.96 | 59.8 | Upgrade
|
Long-Term Deferred Tax Liabilities | - | - | - | 0.56 | - | - | Upgrade
|
Other Long-Term Liabilities | - | 8.49 | - | - | - | - | Upgrade
|
Total Liabilities | 2,926 | 4,031 | 4,223 | 3,326 | 677.22 | 313.98 | Upgrade
|
Common Stock | 247.45 | 247.45 | 247.45 | 247.45 | 247.45 | 222.65 | Upgrade
|
Additional Paid-In Capital | 6,576 | 6,574 | 6,608 | 6,598 | 6,588 | 1,616 | Upgrade
|
Retained Earnings | -1,662 | -1,440 | 42.71 | 1,150 | -764.69 | -368.05 | Upgrade
|
Treasury Stock | -98.11 | -106.17 | -150.17 | - | - | - | Upgrade
|
Comprehensive Income & Other | 0.2 | -0.18 | 0.12 | - | - | - | Upgrade
|
Total Common Equity | 5,063 | 5,275 | 6,748 | 7,995 | 6,071 | 1,471 | Upgrade
|
Minority Interest | - | 12.81 | 497.51 | 552.84 | - | - | Upgrade
|
Shareholders' Equity | 5,063 | 5,287 | 7,246 | 8,548 | 6,071 | 1,471 | Upgrade
|
Total Liabilities & Equity | 7,990 | 9,319 | 11,469 | 11,874 | 6,748 | 1,784 | Upgrade
|
Total Debt | 2,102 | 2,700 | 2,701 | 1,375 | 142.54 | 166.8 | Upgrade
|
Net Cash (Debt) | 1,181 | 1,430 | 3,246 | 6,408 | 4,971 | 587.99 | Upgrade
|
Net Cash Growth | -34.42% | -55.95% | -49.34% | 28.90% | 745.44% | 1140.99% | Upgrade
|
Net Cash Per Share | 4.78 | 5.80 | 13.14 | 25.91 | 21.56 | 2.85 | Upgrade
|
Filing Date Shares Outstanding | 246.04 | 247.04 | 246.77 | 247.45 | 247.45 | 222.65 | Upgrade
|
Total Common Shares Outstanding | 246.04 | 247.04 | 246.77 | 247.45 | 247.45 | 222.65 | Upgrade
|
Working Capital | 2,598 | 2,616 | 4,805 | 6,428 | 5,011 | 677.82 | Upgrade
|
Book Value Per Share | 20.58 | 21.35 | 27.35 | 32.31 | 24.53 | 6.60 | Upgrade
|
Tangible Book Value | 4,944 | 5,130 | 6,527 | 7,823 | 6,034 | 1,451 | Upgrade
|
Tangible Book Value Per Share | 20.10 | 20.77 | 26.45 | 31.61 | 24.38 | 6.52 | Upgrade
|
Buildings | - | 978.89 | 729.03 | 724.68 | 37.19 | 37.19 | Upgrade
|
Machinery | - | 1,189 | 1,050 | 537.75 | 120.73 | 81.48 | Upgrade
|
Construction In Progress | - | 1,114 | 1,342 | 820.8 | 760.05 | 479.04 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.